×

Sign In

Astrazeneca’s breast cancer drug fails late-stage trial

By Thomson Reuters Sep 11, 2026 | 4:33 PM

Sept 11 (Reuters) – AstraZeneca ‌said on Friday ‌its breast ⁠cancer ⁠drug failed to ⁠meet ⁠the main goal of improving ‌progression-free survival ⁠during a late-stage ⁠trial.

(Reporting ‌by ⁠Christy Santhosh ‌in Bengaluru; ⁠Editing by Tasim Zahid)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

'It's all coming back to me now': Celine Dion returns to the stage in Paris

Tesla eyes European freight market with long-delayed Semi truck

Commanders release veteran OT D.J. Humphries

Astrazeneca's breast cancer drug fails late-stage trial

Reports: Bears, RB D'Andre Swift agree to 3-year, $33.75M extension

North Korea launches unidentified projectile toward East Sea, Yonhap reports